Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP267150.RAHU58cyDr7Gm6HnXGC_6_bdLQyGXVypEAzsnnAZg4EPM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP267150.RAHU58cyDr7Gm6HnXGC_6_bdLQyGXVypEAzsnnAZg4EPM130_assertion type Assertion NP267150.RAHU58cyDr7Gm6HnXGC_6_bdLQyGXVypEAzsnnAZg4EPM130_head.
- NP267150.RAHU58cyDr7Gm6HnXGC_6_bdLQyGXVypEAzsnnAZg4EPM130_assertion description "[These results suggest that lymphomas carrying variants of the NPM-ALK fusion protein can be detected by immunostaining for ALK and NPM and also that they can be grouped with classical t(2;5)-positive tumors as a single entity (ALK-positive lymphoma or ALKoma) that shows a better prognosis than ALK-negative anaplastic large-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP267150.RAHU58cyDr7Gm6HnXGC_6_bdLQyGXVypEAzsnnAZg4EPM130_provenance.
- NP267150.RAHU58cyDr7Gm6HnXGC_6_bdLQyGXVypEAzsnnAZg4EPM130_assertion evidence source_evidence_literature NP267150.RAHU58cyDr7Gm6HnXGC_6_bdLQyGXVypEAzsnnAZg4EPM130_provenance.
- NP267150.RAHU58cyDr7Gm6HnXGC_6_bdLQyGXVypEAzsnnAZg4EPM130_assertion SIO_000772 10552961 NP267150.RAHU58cyDr7Gm6HnXGC_6_bdLQyGXVypEAzsnnAZg4EPM130_provenance.
- NP267150.RAHU58cyDr7Gm6HnXGC_6_bdLQyGXVypEAzsnnAZg4EPM130_assertion wasDerivedFrom befree-2016 NP267150.RAHU58cyDr7Gm6HnXGC_6_bdLQyGXVypEAzsnnAZg4EPM130_provenance.
- NP267150.RAHU58cyDr7Gm6HnXGC_6_bdLQyGXVypEAzsnnAZg4EPM130_assertion wasGeneratedBy ECO_0000203 NP267150.RAHU58cyDr7Gm6HnXGC_6_bdLQyGXVypEAzsnnAZg4EPM130_provenance.